MoneyWorks4Me

Shilpa Medicare informs about updates

28 Jul 2021 Evaluate

Shilpa Medicare has informed today about the receipt of confirmation of WHO-GENEVA approval for API, Tenofovir Disoproxil Fumarate, a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS, under pre-qualification program.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..